Observational study / 2019
In psoriatic arthritis patients, serum TMAO levels were significantly associated with measures of disease activity in both skin and peripheral joints.
Researchers investigated the relationship between serum choline metabolites and inflammation in 38 patients with psoriatic arthritis (PsA). Outcomes including Disease Activity Score (DAS)28, Clinical Disease Index (CDAI), and Body Surface Area (BSA) were evaluated alongside serum metabolite levels measured by LC-MS. Among the patients, the mean DAS28PCR was 2.74 ± 1.29, and 27 had active skin disease with an average BSA of 7.2 ± 16.22. TMAO, but not TMA, choline, betaine, or carnitine, was significantly correlated with measures of disease activity for both skin and peripheral joints.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional observational study
- Who was studied
- 38 patients with psoriatic arthritis fulfilling CASPAR criteria
- What was measured
- Correlation of serum choline metabolites with disease activity scores (DAS28, CDAI, BSA)
THE PAPER
Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritis.
Coras R, Kavanaugh A, Boyd T, Huynh D, Lagerborg KA, Xu YJ, Rosenthal SB, Jain M, Guma M. Clin Exp Rheumatol, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.